fixes term-tracker format for OBI terms

src/ontology/modules/study-designs.owl

@@ -2249,7 +2249,7 @@
         <obo:IAO_0000115 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">A study design where the selection of the individuals that are included into the study are intended to be representative of all individuals in the a priori defined specific population and is done at the population level or among the population groups, generally to find the cause, incidence or spread of the disease or to see the response to the treatment, nutrition or environment.</obo:IAO_0000115>
         <obo:IAO_0000117 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">Chris Stoeckert</obo:IAO_0000117>
         <obo:IAO_0000119 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">https://link.springer.com/referenceworkentry/10.1007%2F978-1-4419-1005-9_45, EFO_0001430 population based design</obo:IAO_0000119>
-        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">#1090</obo:IAO_0000233>
+        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#string">https://github.com/obi-ontology/obi/issues/1090</obo:IAO_0000233>
         <rdfs:label rdf:datatype="http://www.w3.org/2001/XMLSchema#string">population based design</rdfs:label>
     </owl:Class>
 

src/ontology/obi-edit.owl

@@ -19700,7 +19700,7 @@ https://www.doi.org/</obo:IAO_0000119>
         <obo:IAO_0000115>An inclusion criterion that is based on fitting within the defined characteristics of a population based study design.</obo:IAO_0000115>
         <obo:IAO_0000117>Chris Stoeckert, Mathias Brochhausen</obo:IAO_0000117>
         <obo:IAO_0000119>MIABIS 2.0</obo:IAO_0000119>
-        <obo:IAO_0000233 rdf:datatype="http://www.w3.org/2001/XMLSchema#integer">920</obo:IAO_0000233>
+        <obo:IAO_0000233>https://github.com/obi-ontology/obi/issues/920</obo:IAO_0000233>
         <obo:IAO_0000234>MIABIS 2.0</obo:IAO_0000234>
         <rdfs:label xml:lang="en">defined population inclusion criterion</rdfs:label>
     </owl:Class>
@@ -20087,7 +20087,7 @@ https://www.doi.org/</obo:IAO_0000119>
         <obo:IAO_0000112 xml:lang="en">&quot;18-33 years old&quot;</obo:IAO_0000112>
         <obo:IAO_0000115>An inclusion criterion that defines and states an age bracket which, if met, makes an entity suitable for a given task or participation in a given process.</obo:IAO_0000115>
         <obo:IAO_0000117>Mathias Brochhausen</obo:IAO_0000117>
-        <obo:IAO_0000233>#839</obo:IAO_0000233>
+        <obo:IAO_0000233>https://github.com/obi-ontology/obi/issues/839</obo:IAO_0000233>
         <rdfs:label xml:lang="en">age group inclusion criterion</rdfs:label>
     </owl:Class>
 
@@ -20122,7 +20122,7 @@ https://www.doi.org/</obo:IAO_0000119>
         <obo:IAO_0000112 xml:lang="en">&quot;received at least 2 days of vancomycin&quot;</obo:IAO_0000112>
         <obo:IAO_0000115 xml:lang="en">An inclusion criterion that defines and states a a set of medications, which, if used by an entity, makes that entity suitable for a given task or participation in a given process.</obo:IAO_0000115>
         <obo:IAO_0000117 xml:lang="en">Mathias Brochhausen</obo:IAO_0000117>
-        <obo:IAO_0000233 xml:lang="en">#840</obo:IAO_0000233>
+        <obo:IAO_0000233 xml:lang="en">https://github.com/obi-ontology/obi/issues/840</obo:IAO_0000233>
         <rdfs:label xml:lang="en">use of medication inclusion criterion</rdfs:label>
     </owl:Class>
 
@@ -22084,7 +22084,7 @@ b) that the amount of analyte/measurand detected is over some predetermined thre
         <obo:IAO_0000119>IEDB</obo:IAO_0000119>
         <rdfs:label>administering substance in vivo to reduce or prevent disease</rdfs:label>
     </owl:Class>
-
+    
 
 
     <!-- http://purl.obolibrary.org/obo/OBI_0003416 -->

src/ontology/templates/study-designs.tsv

@@ -75,7 +75,7 @@ OBI:0002614	birth cohort study design				A cohort study design for which the sub
 OBI:0002615	disease specific study design				A study design for which material and information is collected from subjects that have already developed a particular disease.	MIABIS contributors	A study of the symptoms experienced by patients who have been diagnosed with multiple sclerosis employs a disease specific study design.	MIABIS					subclass	study design						
 OBI:0002624	case-control study design				A study design that entails the creation of two types of roles, such that each participant under investigation bears one or the other. What distinguishes the two types of roles is an 'outcome', which is associated with participants that have the case role but not associated with participants that have the control role. A case-control study examines the hypothesis that the presence of the outcome in case participants is associated with an 'exposure' that is not associated with control participants.	Wikipedia, OBI		John Judkins, Bjoern Peters					subclass	study design						
 OBI:0002674	case series design	case series study design	ready for release		A study design that samples only subjects who have experienced a particular event (outcome or exposure). Such a design, in contrast to a cohort study, does not permit calculation of absolute risk as non-case subjects are not included.	https://www.ncbi.nlm.nih.gov/pubmed/22213493	PMID: 22213493	http://orcid.org/0000-0002-8844-9165 					subclass	study design						
-OBI:0002945	population based design	population based design			A study design where the selection of the individuals that are included into the study are intended to be representative of all individuals in the a priori defined specific population and is done at the population level or among the population groups, generally to find the cause, incidence or spread of the disease or to see the response to the treatment, nutrition or environment.	https://link.springer.com/referenceworkentry/10.1007%2F978-1-4419-1005-9_45, EFO_0001430 population based design		Chris Stoeckert				#1090	subclass	study design						
+OBI:0002945	population based design	population based design			A study design where the selection of the individuals that are included into the study are intended to be representative of all individuals in the a priori defined specific population and is done at the population level or among the population groups, generally to find the cause, incidence or spread of the disease or to see the response to the treatment, nutrition or environment.	https://link.springer.com/referenceworkentry/10.1007%2F978-1-4419-1005-9_45, EFO_0001430 population based design		Chris Stoeckert				https://github.com/obi-ontology/obi/issues/1090	subclass	study design						
 OBI:0003291	in silico design				A study design that is executed primarily on a computer.	https://en.wikipedia.org/wiki/In_silico		Hector Guzman-Orozco			CMI-PB	https://github.com/obi-ontology/obi/issues/1430	subclass	study design						
 OBI:0300310	sequential design	sequential design	pending final vetting		Any design in which the decision as to whether to enroll the next patient, pair of patients, or block of patients is determined by whether the cumulative treatment difference for all previous patients is within specified limits.  Enrollment is continued if the difference does not exceed the limits.  It is terminated if it does	MUSC	PMID: 17710740.Pharm Stat. 2007 Aug 20.Sequential design approaches for bioequivalence studies with crossover designs.	Philippe Rocca-Serra		Provenance: OCI			subclass	intervention design						
 OBI:0300311	observation design	observation design	pending final vetting		observation design is a study design in which subjects are monitored in the absence of any active intervention by experimentalists.	OBI branch derived	PMID: 12387964.Lancet. 2002 Oct 12;360(9340):1144-9.Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study.	Philippe Rocca-Serra					subclass	study design